"Designing Growth Strategies is in our DNA"

U.S. Vaginal Atrophy Treatment Market Size, Share & Industry Analysis, By Therapy Type (Drug Therapies {Estrogen Based [Imvexxy, Premarin, and Others], Non-Estrogen Based [Intrarosa and Osphena]}), Non Drug Therapies {(Hyaluronic-Acid (HA) Based OTC Solutions [HA Vaginal Suppositories/Inserts, HA Gels & Creams, Others], Others OTC Moisturizers & Lubricants, Light Therapy, Lasers, and Others}), By Route of Administration (Oral, Parenteral, and Topical {Vaginal Inserts / Suppositories, Gels & Creams, & Others}) By Distribution Channel, and Country Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI109727

 


U.S. Vaginal Atrophy Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 135
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann